Media

Media

Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

DateTitle
06/15/18GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress
06/08/18GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Research’s 12th Annual Symposium
06/05/18GBT Announces New Employment Inducement Grants
05/17/18GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress

More »

Media Resources

Stay Informed

Sign up to receive email updates about ongoing sickle cell disease clinical studies, awareness and educational information and GBT news at: enroll.gbt.com

Media Contact

Julie Normart
415-946-1087
media@gbt.com